Evidence map›Paper›PMID 31544897›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2019

Long Non-Coding RNA (LncRNA) UFC1/miR-34a Contributes to Proliferation and Migration in Breast Cancer.

Ruilian Xie, Maoyuan Wang, Wenting Zhou, Dan Wang, Yan Yuan, Huaqiu Shi, Longqiu Wu

Open access · bronzeAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. The role of CXC chemokines and receptors in breast cancer.Clinical and experimental medicine · 2025
    Review
  4. MicroRNAs: A Link between Mammary Gland Development and Breast Cancer.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ruilian XieDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
Maoyuan WangDepartment of Rehabilitation, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
Wenting ZhouDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
Dan WangDepartment of Anesthesiology, Ganzhou People's Hospital, The Ganzhou Hospital Affiliated of Nanchang University, Gannan, Jiangxi, China (mainland).
Yan YuanDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
Huaqiu ShiDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
Longqiu WuDepartment of Oncology, The First Affiliated Hospital of Gannan Medical University, Gannan, Jiangxi, China (mainland).
First Affiliated Hospital of Gannan Medical University · CNGanzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND At present, a number of long non-coding RNAs (lncRNAs) have been realized as the critical regulators of breast cancers. Current evidence indicates that dysregulation of UFC1 contributes to the tumorigenesis and progression of various types of human cancer. However, the roles of UFC1 in breast cancer are still unclear. MATERIAL AND METHODS Firstly, we measured the expression of UFC1 in breast cancer tissues and cells lines compared with corresponding controls. Then, cell functional assays were performed to determine the roles of UFC1 in breast cancer progression in vitro. Moreover, the correlation between UFC1 and miR-34a was determined by luciferase reporter assays. Further, the role of miR-34a in regulating biological function of breast cancer and its downstream target CXCL10 was applied by a series of functional assays. RESULTS In present study, we found that UFC1 was highly expressed in breast tissue and cells lines compared with normal tissues and cell lines. Silenced UFC1 suppressed multiple biological activities of breast cancer cells, which also functioned as a miR-34a sponge in breast cancer. Furthermore, over-expressing miR-34a could prominently suppress cell growth, invasion, migration and inducing apoptosis in breast cancer cells. In addition, we verified that miR-34a was a target of CXCL10 by bioinformatics analysis and luciferase reporter assay. CONCLUSIONS LncRNA UFC1 regulated biological activity of breast cancer via miR-34a/CXCL10 axis, providing a novel diagnosis biomarker and potential therapeutic target for breast cancer.

Indexed as

Base SequenceBreast NeoplasmsCell Line, TumorCell MovementCell ProliferationChemokine CXCL10FemaleGene Expression Regulation, NeoplasticGene SilencingHumansMicroRNAsPrognosisRNA, Long NoncodingChemokine CXCL10CXCL10 protein, humanMicroRNAsMIRN34 microRNA, humanRNA, Long Noncoding

Identifiers

PMID31544897
PMCPMC6777379
OpenAlexW2976434001

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.